Natixis Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-12,972
Closed -$325K 1325
2021
Q1
$325K Buy
+12,972
New +$244K ﹤0.01% 1225

Other funds holding PRTA

Natixis Advisors's PRTA Position: Q2 2021 in Review

Natixis Advisors sold out of Prothena Corp (PRTA) in Q2 2021, closing a stake of 12,972 shares — an estimated $325K sold.

Natixis Advisors first reported a position in PRTA in Q1 2021 and held it in 1 quarter. The position peaked at $325K in Q1 2021. 156 funds tracked by Wall St. Rank hold PRTA as of Q2 2021.

  • Natixis Advisors reported no remaining Prothena Corp position as of Q2 2021 after selling out during the quarter.
  • Natixis Advisors sold 12,972 Prothena Corp shares in Q2 2021, an estimated $325K.
  • Natixis Advisors first reported a position in Prothena Corp in Q1 2021 and held it in 1 quarter.
  • Natixis Advisors's Prothena Corp position peaked at $325K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2021.

Based on Natixis Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.